| 174331 | 174331 | Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva | Completed | No Results Available | Pulmonary Disease, Chronic Obstructive | Drug: Tiotropium + placebo|Drug: Tiotropium + ipratropium|Drug: Tiotropium + fenoterol | https://ClinicalTrials.gov/show/NCT00274066 |
| 174332 | 174332 | Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD | Completed | No Results Available | Pulmonary Disease, Chronic Obstructive | Drug: tiotropium | https://ClinicalTrials.gov/show/NCT00274053 |
| 174333 | 174333 | Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD | Completed | No Results Available | Pulmonary Disease, Chronic Obstructive | Drug: Tiotropium|Drug: Ipratropium | https://ClinicalTrials.gov/show/NCT00274040 |
| 174334 | 174334 | Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva) | Completed | No Results Available | Pulmonary Disease, Chronic Obstructive | Drug: tiotropium bromide | https://ClinicalTrials.gov/show/NCT00274027 |
| 174335 | 174335 | Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders | Completed | No Results Available | Pulmonary Disease, Chronic Obstructive | Drug: Tiotropium | https://ClinicalTrials.gov/show/NCT00274014 |
| 174336 | 174336 | Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients | Completed | No Results Available | HIV Infections|Quality of Life | Drug: Nevirapine | https://ClinicalTrials.gov/show/NCT00274001 |
| 174337 | 174337 | Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent Adults | Completed | No Results Available | Acquired Immunodeficiency Syndrome | Drug: nevirapine | https://ClinicalTrials.gov/show/NCT00273988 |
| 174338 | 174338 | Trial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric Patients | Completed | No Results Available | HIV Infections | Drug: Nevirapine|Drug: Lamivudine|Drug: Zidovudine | https://ClinicalTrials.gov/show/NCT00273975 |
| 174339 | 174339 | A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg) | Completed | No Results Available | Asthma | Drug: ipratropium plus salbutamol UDV|Drug: salbutamol UDV | https://ClinicalTrials.gov/show/NCT00273962 |
| 174340 | 174340 | Lactulose for the Prevention of Nosocomial Infections in Children | Active, not recruiting | No Results Available | Nosocomial Infection | Drug: lactulose | https://ClinicalTrials.gov/show/NCT00273949 |
| 174341 | 174341 | Trial of AVN-944 in Patients With Advanced Hematologic Malignancies | Completed | No Results Available | Acute Leukemia|Chronic Leukemia|Multiple Myeloma|Hodgkin's Lymphoma|Non-Hodgkin's Lymphoma|Waldenstrom's Macroglobulinemia | Drug: AVN-944 capsules for oral administration | https://ClinicalTrials.gov/show/NCT00273936 |
| 174342 | 174342 | Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma | Completed | Has Results | High-Risk Melanoma | Drug: gp100:209-217 (210M)|Drug: Montanide ISA-51|Drug: Imiquimod | https://ClinicalTrials.gov/show/NCT00273910 |
| 174343 | 174343 | Electrical Polarization of the Brain in Corticobasal Syndrome | Completed | No Results Available | Corticobasal Syndrome | Device: Phoresor II | https://ClinicalTrials.gov/show/NCT00273897 |
| 174344 | 174344 | Amonafide in Combination With Cytarabine in Secondary AML | Completed | No Results Available | Acute Myeloid Leukemia | Drug: Amonafide L-Malate|Drug: Cytarabine | https://ClinicalTrials.gov/show/NCT00273884 |
| 174345 | 174345 | Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients | Completed | No Results Available | Graft Rejection|Kidney Failure|Kidney Transplantation | Drug: Cyclosporin or tacrolimus | https://ClinicalTrials.gov/show/NCT00273871 |
| 174346 | 174346 | Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis | Terminated | Has Results | Ankylosing Spondylitis|Arthritis, Psoriatic|Arthritis, Rheumatoid|Spondylitis, Ankylosing | Other: There is no Intervention. The study is observational. | https://ClinicalTrials.gov/show/NCT00273858 |
| 174347 | 174347 | Reducing Barriers to Drug Abuse Treatment Services | Completed | No Results Available | Substance Abuse | Behavioral: Motivational interviewing|Behavioral: Strengths-Based Case Management | https://ClinicalTrials.gov/show/NCT00273845 |
| 174348 | 174348 | Study of Coronary Artery Computed Tomography to Diagnose Emergency Chest Pain | Completed | No Results Available | Chest Pain|Angina Pectoris|Myocardial Infarction | Procedure: coronary artery computed tomography angiogram|Procedure: single photon emission computed tomography | https://ClinicalTrials.gov/show/NCT00273832 |
| 174349 | 174349 | Study of Coronary Artery Disease by Two Types of Angiography | Completed | No Results Available | Congestive Heart Failure | Procedure: CT angiography | https://ClinicalTrials.gov/show/NCT00273819 |
| 174350 | 174350 | A Medical Assistant-Based Program to Promote Healthy Behaviors in Primary Care | Completed | No Results Available | Smoking|Problem Drinking|Sedentary Lifestyle|Unhealthy Diet | Behavioral: Intervention for 4 behavioral risks by medical assistants. | https://ClinicalTrials.gov/show/NCT00273806 |
| 174351 | 174351 | Increasing Contingency Management Success in Smoking Cessation | Completed | Has Results | Smoking | Behavioral: Contingency Management | https://ClinicalTrials.gov/show/NCT00273793 |
| 174352 | 174352 | Highly Active Antiretroviral Therapy (HAART) Adherence Interventions | Completed | No Results Available | HIV Infections | Behavioral: Adherence counseling|Device: Alarm device | https://ClinicalTrials.gov/show/NCT00273780 |
| 174353 | 174353 | Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB | Completed | No Results Available | Myocardial Ischemia | Drug: epoetin beta|Drug: placebo | https://ClinicalTrials.gov/show/NCT00273767 |
| 174354 | 174354 | The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA). | Completed | Has Results | Sleep Apnea, Obstructive|Tonsillectomy|Adenoidectomy|Postoperative Complications | Drug: Caffeine|Drug: Placebo | https://ClinicalTrials.gov/show/NCT00273754 |
| 174355 | 174355 | Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients | Terminated | No Results Available | Asthenia|Neoplasms | Drug: methylphenidate|Drug: placebo comparator | https://ClinicalTrials.gov/show/NCT00273741 |
| 174356 | 174356 | BaSES Trial: Basel Starch Evaluation in Sepsis | Completed | No Results Available | Sepsis|Severe Sepsis|Septic Shock | Drug: hydroxy-ethyl starch (MW 130; 0.4) vs. normal saline | https://ClinicalTrials.gov/show/NCT00273728 |
| 174357 | 174357 | Study of Sutures Versus Staples for Skin Closure After Surgical Procedures of Hip | Completed | No Results Available | Surgery | Procedure: Surgical wound closure techniques|Procedure: Surgical wound closure techniques (Comparator) | https://ClinicalTrials.gov/show/NCT00273715 |
| 174358 | 174358 | An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling | Completed | No Results Available | Pathological Gambling | Drug: N-Acetyl Cysteine | https://ClinicalTrials.gov/show/NCT00273702 |
| 174359 | 174359 | Exercise Induced Bronchospasm in Children | Completed | No Results Available | Exercise Induced Bronchospasm | Drug: montelukast vs pretreatment with albuterol|Drug: montelukast | https://ClinicalTrials.gov/show/NCT00273689 |
| 174360 | 174360 | Study on Costs and Safety of Early Conversion From Intravenous to Oral Antibiotic Treatment in Patients With Severe Community-Acquired Pneumonia | Completed | No Results Available | Severe Communtity-Acquired Pneumonia | Procedure: Conversion to oral antibiotic treatment after 3 days of intravenous antibiotic treatment | https://ClinicalTrials.gov/show/NCT00273676 |